I recently contacted Glaxosmithkline regarding avodart and hair loss, and this is what they said.
“Thank you for contacting GlaxoSmithKline about AVODARTÂ® (dutasteride).
GSK will not be pursuing further studies on the use of dutasteride for AGA (alopecia – male pattern hair loss). This decision is based on market research analyses and not for any safety or efficacy reasons.
A copy of the prescribing information for this product is available at https://us.gsk.com/products/assets/us_avodart.pdf for review and discussion with an appropriate healthcare provider.
We appreciate the opportunity to serve you. If you have further questions concerning GlaxoSmithKline or our products, please contact our Response Center at 1-888-825-5249 during our normal business hours, Monday through Friday 8:00 A.M. to 6:00 P.M. (Eastern Time).
This is a send only email address. Please do not reply to this email.”
what does it mean that they won’t pursue further studies because of market research analysis?
Some doctors in the know have told me for some time that GlaxoSmithKline (GSK) had no real intention to get into the hair business with Avodart, but their recent study may have reflected their playing the options for the future. According to the ClinicalTrials.gov site, GSK is still recruiting participants in a study of Korean patients to be concluded in July 2013… so I really don’t know what they’re doing.
As I am not an insider, I really can only speculate like everyone else.